期刊文献+

细胞色素P450与基质金属蛋白酶-26在宫颈癌中的表达

Expression of Cytochrome P450 and Matrix Metalloproteinase-26 in Cervical Cancer
下载PDF
导出
摘要 目的探讨CYP1A1及MMP-26在正常子宫颈、宫颈上皮内瘤变(CIN)、宫颈癌中的表达及临床意义。方法采用免疫组织化学法检测CYP1A1及MMP-26在35例正常子宫颈、46例CIN、29例宫颈癌中的表达情况。结果 CIN组、宫颈癌组织中CYP1A1及MMP-26的表达明显高于正常宫颈组织,差异有统计学意义。二者宫颈癌癌中的表达明显高于宫颈上皮内瘤变组织,差异有统计学意义。在CIN不同病理分级中,CINⅢ中的阳性表达明显高于CINⅡ级、CINⅠ级,而CINⅡ级与CINⅠ级比较无统计学意义(P>0.05)。结论 CYP1A1及MMP-26的表达与宫颈癌的形成与发展有着密切的关系。 Objective To study the expression of cytochrome P4501 A1(CYP1 A1)and matrix metalloproteinase-26(MMP-26)in normal cervical tissue,cervical intraepithelial neoplasia(CIN),and cervical cancer.Methods The expression of CYP1 A1 and MMP-26 in 35 cases of normal cervix,46 cases of CIN,29 cases of cervical cancer were studied by immunohistochemistry.Rusults The positive expression rates of CYP1 A1 and MMP-26 in CIN,cervical cancer were higher than those in normal cervical tissue,which had statistic significance.The positive expression rates of both in cervical cancer were higher than those in CIN.The positive expression rates of CYP1 A1 and MMP-26 in CINⅢwere higher than those in CINⅡand CINⅠ.The expression difference of both in CINⅡand CINⅠhad no statistic significance(p>0.05).Conclusions The expression of CYP1 A1 and MMP-26 protein is closely related to the formation and development of cervical cancer.
作者 齐彩霞 QI Cai-xia(Immunology Institute,Medical School of Shanxi Datong University,Datong Shanxi,037009)
出处 《山西大同大学学报(自然科学版)》 2019年第2期55-57,共3页 Journal of Shanxi Datong University(Natural Science Edition)
基金 山西省自然科学基金项目[2013011045-3] 山西大同大学科研基金项目[2014K2]
关键词 宫颈上皮内瘤变 宫颈癌 CYP1A1 MMP-26 cervical intraepithelial neoplasia(CIN) cervical cancer CYP1A1 MMP-26
  • 相关文献

参考文献2

二级参考文献29

  • 1李庭芳,陈锐.宫颈癌临床流行病学概述[J].实用医院临床杂志,2005,2(2):19-22. 被引量:62
  • 2李秀娟.宫颈癌流行病学及高危因素研究进展[J].实用医技杂志,2006,13(19):3517-3518. 被引量:20
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Forouzanfar MH,Foreman KJ,Delossantos AM,et al.Breast and cervical cancer in 187 countries between 1980 and 2010:a systematic analysis[J].Lancet,2011,378(9801):1461-1484.
  • 5Schiffman M,Castle PE,Jeronimo J,et al.Human papillomavirvs and cervical cancer[J].Lancet,2007,370(9590):890-907.
  • 6Huang M,Chen Q,Xiao J,et al.CYP1A1 Ile462Val is a risk factor for ovarian cancer development[J].Cytokine,2012,58(1):73-78.
  • 7Wang JJ,Zheng Y,Sun L,et al.CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer:a metaanalysis based on32studies[J].Eur J Cancer Prev,2011,20(6):445-452.
  • 8Ahn T,Yun CH.Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes[J].Curr Drug Metab,2010,11(10):830-839.
  • 9Wienkers LC,Heath TG.Predicting in vivo drug interactions from in vitro drug discovery data[J].Nat Rev Drug Discov,2005,4(10):825-33.
  • 10Sissung TM,Price DK,Sparreboom A,et al.Pharmacogenetics and regulation of human cytochrome P450 1 BI:implications in hormone mediated tumor metabolism and a novel target for therapeutic intervention[J].Mol Cancer Res,2006,4(3):135-150.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部